IRadimed Corporation (IRMD) on Decifer

Decifer ranks IRMD number 208 of 277 tracked names on durable business quality.

Why it ranks here

• It earns strong returns on the money it puts to work, around 21% and those returns have been improving and it turns most of its profit into real cash.
• Revenue is growing about 14% a year, profits grew 16% over the past year, and growth is speeding up, not slowing down.
• It keeps a high share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power, with profitability widening as it grows.
• and has the balance sheet to fund its growth.
• We do not have a clean read on how it is run yet.
• Returns around 21% and steady margins are strong, but no worldview role, an unclear read on management, and momentum of 10 out of 35 keep it modest.

The current read

The evidence on IRMD lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Healthcare, Biotech & Devices: IRadimed Corporation operates in medical - devices. That places it inside the Healthcare, Biotech & Devices story.

Read the full IRMD research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.